Decision to list medical devices supplied by Device Technologies New Zealand Limited
We are pleased to announce the approval of listing agreements for the supply of medical devices to DHBs.
What we’re doing
We are pleased to announce the approval of a listing agreement with Device Technologies New Zealand Limited (“Device Technologies”) for the supply of:
In summary this will result in:
- Infusion devices and feeding devices from Device Technologies being listed in Part III of Section H of the Pharmaceutical Schedule from 1 July 2021 under a national agreement that all DHBs may purchase under (“Agreement”); and
- DHBs being able to continue to purchase other suppliers’ brands of infusion and feeding devices as the Agreement is not for sole supply.
Any changes to the original proposal?
No significant changes were made to the proposal as a result of the consultation.
Who we think will be most interested
- DHB staff including but not limited to:
- Procurement officers and supply chain personnel
- Clinical engineers and maintenance services
- ICU, emergency, and critical care staff
- Perioperative care staff
- Nurses (both inpatient and community based)
- Suppliers and wholesalers
Details about this decision
In 2018 PHARMAC issued Requests for Proposals (“RFPs”) for:
- supply of infusion devices (including non-dedicated and consumable infusion devices and infusion equipment and associated devices); and
- supply of feeding devices and/or special foods delivered enterally or orally
The RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
After completing the evaluation process, and consulting on the provisional Agreement reached with Device Technologies, PHARMAC has decided to list this supplier’s infusion and feeding devices, in Part III of Section H of the Pharmaceutical Schedule from 1 July 2021.
Our response to what you told us
We appreciate all responses provided for this consultation.
All consultation responses received by 20 May 2021 were considered in their entirety in making the decision to list Device Technologies’ infusion and feeding devices.
A summary of the main themes raised in feedback and our responses to the feedback are set out below:
Support for the proposal.
No technical or resource impacts anticipated as a result of the proposal.
Concerns from a clinician regarding whether some feeding devices included in this listing would be suitable for DHB needs.
DHBs are able to continue to purchase other suppliers’ brands of Feeding Devices as the Agreement is not for sole supply. Listing this range of devices provides more options for DHBs to choose from to meet their individual requirements.
If you have any questions about this decision, you can email us at email@example.com; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.